首页> 美国卫生研究院文献>Journal of Translational Medicine >Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways
【2h】

Compound α-keto acid tablet supplementation alleviates chronic kidney disease progression via inhibition of the NF-kB and MAPK pathways

机译:化合物α-酮酸片剂补充剂通过抑制NF-kB和MAPK途径缓解慢性肾脏疾病的进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundKeto-analogues administration plays an important role in clinical chronic kidney disease (CKD) adjunctive therapy, however previous studies on their reno-protective effect mainly focused on kidney pathological changes induced by nephrectomy. This study was designed to explore the currently understudied alternative mechanisms by which compound α-ketoacid tablets (KA) influenced ischemia–reperfusion (IR) induced murine renal injury, and to probe the current status of KA administration on staving CKD progression in Chinese CKD patients at different stages.
机译:背景酮类似物的给药在临床慢性肾脏病(CKD)辅助治疗中起着重要作用,但是先前对其肾脏保护作用的研究主要集中于肾切除术引起的肾脏病理变化。本研究旨在探讨目前尚未被研究的其他替代机制,其中复合α-酮酸片(KA)影响缺血再灌注(IR)诱导的鼠肾损伤,并探讨KA给药对中国CKD患者延缓CKD进展的现状在不同的阶段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号